These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 7954462

  • 21. [Expression of human-mouse chimeric antibody ch-BD1 and its affinity to human bladder cancer in vitro and in vivo].
    Bai Y, Yu LZ, Lü YQ, Ai JK, Zhou LJ, Zhang CL, Wang Y.
    Zhonghua Yi Xue Za Zhi; 2003 Feb 25; 83(4):333-7. PubMed ID: 12812655
    [Abstract] [Full Text] [Related]

  • 22. Human lymphocyte and monocyte lysis of tumor cells mediated by a mouse/human IgG1 chimeric monoclonal antibody.
    Shaw DR, Harrison G, Sun LK, Shearman C, Ghrayeb J, McKinney S, Daddona PE, LoBuglio AF.
    J Biol Response Mod; 1988 Apr 25; 7(2):204-11. PubMed ID: 3361351
    [Abstract] [Full Text] [Related]

  • 23. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
    Weiner LM, Holmes M, Adams GP, LaCreta F, Watts P, Garcia de Palazzo I.
    Cancer Res; 1993 Jan 01; 53(1):94-100. PubMed ID: 8093231
    [Abstract] [Full Text] [Related]

  • 24. Self-reactive antibody expression by human carcinoma cells engineered with monoclonal antibody genes.
    Primus FJ, Finch MD, Masci AM, Schlom J, Kashmiri SV.
    Cancer Res; 1993 Jul 15; 53(14):3355-61. PubMed ID: 8324746
    [Abstract] [Full Text] [Related]

  • 25. Monoclonal antibody homodimers: enhanced antitumor activity in nude mice.
    Wolff EA, Schreiber GJ, Cosand WL, Raff HV.
    Cancer Res; 1993 Jun 01; 53(11):2560-5. PubMed ID: 8495420
    [Abstract] [Full Text] [Related]

  • 26. [Primary characterization and sequence analysis of anti-colorectal cancer phage fusion antibodies].
    Zhu JG, Hu JY, Li GC.
    Hunan Yi Ke Da Xue Xue Bao; 2002 Apr 28; 27(2):95-8. PubMed ID: 12575327
    [Abstract] [Full Text] [Related]

  • 27. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen.
    Sahagan BG, Dorai H, Saltzgaber-Muller J, Toneguzzo F, Guindon CA, Lilly SP, McDonald KW, Morrissey DV, Stone BA, Davis GL.
    J Immunol; 1986 Aug 01; 137(3):1066-74. PubMed ID: 3088107
    [Abstract] [Full Text] [Related]

  • 28. Immunotherapy with low and high affinity monoclonal antibodies 17-1A and 323/A3 in a nude mouse xenograft carcinoma model.
    Velders MP, van Rhijn CM, Briaire IH, Fleuren GJ, Warnaar SO, Litvinov SV.
    Cancer Res; 1995 Oct 01; 55(19):4398-403. PubMed ID: 7671252
    [Abstract] [Full Text] [Related]

  • 29. Recombinant human-mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen.
    Nishimura Y, Yokoyama M, Araki K, Ueda R, Kudo A, Watanabe T.
    Cancer Res; 1987 Feb 15; 47(4):999-1005. PubMed ID: 2948638
    [Abstract] [Full Text] [Related]

  • 30. Characterization of a human T cell-specific chimeric antibody (CD7) with human constant and mouse variable regions.
    Heinrich G, Gram H, Kocher HP, Schreier MH, Ryffel B, Akbar A, Amlot PL, Janossy G.
    J Immunol; 1989 Dec 01; 143(11):3589-97. PubMed ID: 2479683
    [Abstract] [Full Text] [Related]

  • 31. Construction of a chimeric antibody with therapeutic potential for cancers which overexpress c-erbB-2.
    Liu HL, Parkes DL, Langton BC, Xuan JA, Longhi M, Elliger SS, Chao LA, McGrogan MP, Brandis JW, Shawver LK.
    Biochem Biophys Res Commun; 1995 Jun 26; 211(3):792-803. PubMed ID: 7598708
    [Abstract] [Full Text] [Related]

  • 32. Differential effects of a murine and chimeric mouse/human anti-interleukin-2 receptor antibody on human T-cell proliferation.
    Rose B, Gillespie A, Wunderlich D, Kelley K, Dzuiba J, Shedd D, Cahill K, Zerler B.
    Immunology; 1992 Jul 26; 76(3):452-9. PubMed ID: 1526654
    [Abstract] [Full Text] [Related]

  • 33. Anti-BA46 monoclonal antibody Mc3: humanization using a novel positional consensus and in vivo and in vitro characterization.
    Couto JR, Blank EW, Peterson JA, Ceriani RL.
    Cancer Res; 1995 Apr 15; 55(8):1717-22. PubMed ID: 7712480
    [Abstract] [Full Text] [Related]

  • 34. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.
    Kawata A, Yoshida M, Okazaki M, Yokota S, Barcos M, Seon BK.
    Cancer Res; 1994 May 15; 54(10):2688-94. PubMed ID: 8168098
    [Abstract] [Full Text] [Related]

  • 35. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
    Hernandez-Ilizaliturri FJ, Jupudy V, Ostberg J, Oflazoglu E, Huberman A, Repasky E, Czuczman MS.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5866-73. PubMed ID: 14676108
    [Abstract] [Full Text] [Related]

  • 36. Humanized anti-Lewis Y antibodies: in vitro properties and pharmacokinetics in rhesus monkeys.
    Co MS, Baker J, Bednarik K, Janzek E, Neruda W, Mayer P, Plot R, Stumper B, Vasquez M, Queen C, Loibner H.
    Cancer Res; 1996 Mar 01; 56(5):1118-25. PubMed ID: 8640770
    [Abstract] [Full Text] [Related]

  • 37. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
    Woodhouse CS, Morgan AC.
    Cancer Res; 1989 May 15; 49(10):2766-72. PubMed ID: 2713860
    [Abstract] [Full Text] [Related]

  • 38. Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy.
    Yang XD, Jia XC, Corvalan JR, Wang P, Davis CG, Jakobovits A.
    Cancer Res; 1999 Mar 15; 59(6):1236-43. PubMed ID: 10096554
    [Abstract] [Full Text] [Related]

  • 39. Antigen binding and biological activities of engineered mutant chimeric antibodies with human tumor specificities.
    Gillies SD, Wesolowski JS.
    Hum Antibodies Hybridomas; 1990 Mar 15; 1(1):47-54. PubMed ID: 2129419
    [Abstract] [Full Text] [Related]

  • 40. Mouse/human chimeric Me1-14 antibody: genomic cloning of the variable region genes, linkage to human constant region genes, expression, and characterization.
    Batra SK, Niswonger ML, Wikstrand CJ, Pegram CN, Zalutsky MR, Morrison SL, Bigner DD.
    Hybridoma; 1994 Apr 15; 13(2):87-97. PubMed ID: 8050781
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.